Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study.

Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study. Urology. 2015 Dec; 86(6):1206-11.

View in: PubMed

subject areas

Adenocarcinoma
Aged
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Disease Progression
Everolimus
Humans
Male
Neoplastic Cells, Circulating
Phosphorylation
Prednisone
Prostate-Specific Antigen
Prostatic Neoplasms, Castration-Resistant
Proto-Oncogene Proteins c-akt
Survival Rate
Taxoids
TOR Serine-Threonine Kinases
Tumor Suppressor Proteins

authors with profiles

Daniel H. Shevrin